Global Active Pharmaceutical Ingredient Market Insights and Forecast to 2026
- BMR3911207
- 188 Pages
- June 2020
- Healthcare
Prior to COVID-19, the market for Active Pharmaceutical Ingredient was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of XX% during 2021–2026, whereas post-COVID-19 scenario, the market for Active Pharmaceutical Ingredient is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Active Pharmaceutical Ingredient market.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Active Pharmaceutical Ingredient market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Active Pharmaceutical Ingredient industry.
Global Active Pharmaceutical Ingredient Scope and Segment
Active Pharmaceutical Ingredient market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Active Pharmaceutical Ingredient market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
The following manufacturers are covered in this report:
Teva
Novartis
Pfizer
Johnson & Johnson
Mylan
North China Pharmaceutical Group
Dr. Reddy’s Laboratories
Roche
Aurobindo pharma
Sun Pharmaceutical Industries
Boehringer Ingelheim GmbH
Bayer
BASF
DSM
Zhejiang Medicine
Biocon
Johnson Matthey
Hisun Pharmacy
Cambrex
Shandong Xinhua Pharmaceutical
Lonza group
Huahai Pharmaceutical
Haerbin Pharmaceutical Group
Cipla
Tian Yao
Lupin
North East Pharmaceutical
Albemarle
Shandong Lukang Pharmaceutical
Jiangsu Hengrui Medicine
Active Pharmaceutical Ingredient Breakdown Data by Type
Synthetic API
Biotech API
Other
Active Pharmaceutical Ingredient Breakdown Data by Application
Chemical
Deodorant
Dailylife
Regional and Country-level Analysis
The Active Pharmaceutical Ingredient market is analysed and market size information is provided by regions (countries).
The key regions covered in the Active Pharmaceutical Ingredient market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Active Pharmaceutical Ingredient Market Share Analysis
1.1 Active Pharmaceutical Ingredient Product Introduction
1.2 Market Segments
1.3 Key Active Pharmaceutical Ingredient Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Active Pharmaceutical Ingredient Market Size Growth Rate by Type
1.4.2 Synthetic API
1.4.3 Biotech API
1.4.4 Other
1.5 Market by Application
1.5.1 Global Active Pharmaceutical Ingredient Market Size Growth Rate by Application
1.5.2 Chemical
1.5.3 Deodorant
1.5.4 Dailylife
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Active Pharmaceutical Ingredient Market Size, Estimates and Forecasts
2.1.1 Global Active Pharmaceutical Ingredient Revenue 2015-2026
2.1.2 Global Active Pharmaceutical Ingredient Sales 2015-2026
2.2 Global Active Pharmaceutical Ingredient, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Active Pharmaceutical Ingredient Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Active Pharmaceutical Ingredient Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Active Pharmaceutical Ingredient Competitor Landscape by Players
3.1 Active Pharmaceutical Ingredient Sales by Manufacturers
3.1.1 Active Pharmaceutical Ingredient Sales by Manufacturers (2015-2020)
3.1.2 Active Pharmaceutical Ingredient Sales Market Share by Manufacturers (2015-2020)
3.2 Active Pharmaceutical Ingredient Revenue by Manufacturers
3.2.1 Active Pharmaceutical Ingredient Revenue by Manufacturers (2015-2020)
3.2.2 Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Active Pharmaceutical Ingredient Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Active Pharmaceutical Ingredient Revenue in 2019
3.2.5 Global Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Active Pharmaceutical Ingredient Price by Manufacturers
3.4 Active Pharmaceutical Ingredient Manufacturing Base Distribution, Product Types
3.4.1 Active Pharmaceutical Ingredient Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Active Pharmaceutical Ingredient Product Type
3.4.3 Date of International Manufacturers Enter into Active Pharmaceutical Ingredient Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Active Pharmaceutical Ingredient Market Size by Type (2015-2020)
4.1.1 Global Active Pharmaceutical Ingredient Sales by Type (2015-2020)
4.1.2 Global Active Pharmaceutical Ingredient Revenue by Type (2015-2020)
4.1.3 Active Pharmaceutical Ingredient Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Active Pharmaceutical Ingredient Market Size Forecast by Type (2021-2026)
4.2.1 Global Active Pharmaceutical Ingredient Sales Forecast by Type (2021-2026)
4.2.2 Global Active Pharmaceutical Ingredient Revenue Forecast by Type (2021-2026)
4.2.3 Active Pharmaceutical Ingredient Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Active Pharmaceutical Ingredient Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Active Pharmaceutical Ingredient Market Size by Application (2015-2020)
5.1.1 Global Active Pharmaceutical Ingredient Sales by Application (2015-2020)
5.1.2 Global Active Pharmaceutical Ingredient Revenue by Application (2015-2020)
5.1.3 Active Pharmaceutical Ingredient Price by Application (2015-2020)
5.2 Active Pharmaceutical Ingredient Market Size Forecast by Application (2021-2026)
5.2.1 Global Active Pharmaceutical Ingredient Sales Forecast by Application (2021-2026)
5.2.2 Global Active Pharmaceutical Ingredient Revenue Forecast by Application (2021-2026)
5.2.3 Global Active Pharmaceutical Ingredient Price Forecast by Application (2021-2026)
6 North America
6.1 North America Active Pharmaceutical Ingredient by Country
6.1.1 North America Active Pharmaceutical Ingredient Sales by Country
6.1.2 North America Active Pharmaceutical Ingredient Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Active Pharmaceutical Ingredient Market Facts & Figures by Type
6.3 North America Active Pharmaceutical Ingredient Market Facts & Figures by Application
7 Europe
7.1 Europe Active Pharmaceutical Ingredient by Country
7.1.1 Europe Active Pharmaceutical Ingredient Sales by Country
7.1.2 Europe Active Pharmaceutical Ingredient Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Active Pharmaceutical Ingredient Market Facts & Figures by Type
7.3 Europe Active Pharmaceutical Ingredient Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Active Pharmaceutical Ingredient by Region
8.1.1 Asia Pacific Active Pharmaceutical Ingredient Sales by Region
8.1.2 Asia Pacific Active Pharmaceutical Ingredient Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Active Pharmaceutical Ingredient Market Facts & Figures by Type
8.3 Asia Pacific Active Pharmaceutical Ingredient Market Facts & Figures by Application
9 Latin America
9.1 Latin America Active Pharmaceutical Ingredient by Country
9.1.1 Latin America Active Pharmaceutical Ingredient Sales by Country
9.1.2 Latin America Active Pharmaceutical Ingredient Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Active Pharmaceutical Ingredient Market Facts & Figures by Type
9.3 Central & South America Active Pharmaceutical Ingredient Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Active Pharmaceutical Ingredient by Country
10.1.1 Middle East and Africa Active Pharmaceutical Ingredient Sales by Country
10.1.2 Middle East and Africa Active Pharmaceutical Ingredient Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Active Pharmaceutical Ingredient Market Facts & Figures by Type
10.3 Middle East and Africa Active Pharmaceutical Ingredient Market Facts & Figures by Application
11 Company Profiles
11.1 Teva
11.1.1 Teva Corporation Information
11.1.2 Teva Description and Business Overview
11.1.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Teva Active Pharmaceutical Ingredient Products Offered
11.1.5 Teva Related Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Description and Business Overview
11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis Active Pharmaceutical Ingredient Products Offered
11.2.5 Novartis Related Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Description and Business Overview
11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer Active Pharmaceutical Ingredient Products Offered
11.3.5 Pfizer Related Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Description and Business Overview
11.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Johnson & Johnson Active Pharmaceutical Ingredient Products Offered
11.4.5 Johnson & Johnson Related Developments
11.5 Mylan
11.5.1 Mylan Corporation Information
11.5.2 Mylan Description and Business Overview
11.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Mylan Active Pharmaceutical Ingredient Products Offered
11.5.5 Mylan Related Developments
11.6 North China Pharmaceutical Group
11.6.1 North China Pharmaceutical Group Corporation Information
11.6.2 North China Pharmaceutical Group Description and Business Overview
11.6.3 North China Pharmaceutical Group Sales, Revenue and Gross Margin (2015-2020)
11.6.4 North China Pharmaceutical Group Active Pharmaceutical Ingredient Products Offered
11.6.5 North China Pharmaceutical Group Related Developments
11.7 Dr. Reddy’s Laboratories
11.7.1 Dr. Reddy’s Laboratories Corporation Information
11.7.2 Dr. Reddy’s Laboratories Description and Business Overview
11.7.3 Dr. Reddy’s Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Products Offered
11.7.5 Dr. Reddy’s Laboratories Related Developments
11.8 Roche
11.8.1 Roche Corporation Information
11.8.2 Roche Description and Business Overview
11.8.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Roche Active Pharmaceutical Ingredient Products Offered
11.8.5 Roche Related Developments
11.9 Aurobindo pharma
11.9.1 Aurobindo pharma Corporation Information
11.9.2 Aurobindo pharma Description and Business Overview
11.9.3 Aurobindo pharma Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Aurobindo pharma Active Pharmaceutical Ingredient Products Offered
11.9.5 Aurobindo pharma Related Developments
11.10 Sun Pharmaceutical Industries
11.10.1 Sun Pharmaceutical Industries Corporation Information
11.10.2 Sun Pharmaceutical Industries Description and Business Overview
11.10.3 Sun Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Products Offered
11.10.5 Sun Pharmaceutical Industries Related Developments
11.1 Teva
11.1.1 Teva Corporation Information
11.1.2 Teva Description and Business Overview
11.1.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Teva Active Pharmaceutical Ingredient Products Offered
11.1.5 Teva Related Developments
11.12 Bayer
11.12.1 Bayer Corporation Information
11.12.2 Bayer Description and Business Overview
11.12.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Bayer Products Offered
11.12.5 Bayer Related Developments
11.13 BASF
11.13.1 BASF Corporation Information
11.13.2 BASF Description and Business Overview
11.13.3 BASF Sales, Revenue and Gross Margin (2015-2020)
11.13.4 BASF Products Offered
11.13.5 BASF Related Developments
11.14 DSM
11.14.1 DSM Corporation Information
11.14.2 DSM Description and Business Overview
11.14.3 DSM Sales, Revenue and Gross Margin (2015-2020)
11.14.4 DSM Products Offered
11.14.5 DSM Related Developments
11.15 Zhejiang Medicine
11.15.1 Zhejiang Medicine Corporation Information
11.15.2 Zhejiang Medicine Description and Business Overview
11.15.3 Zhejiang Medicine Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Zhejiang Medicine Products Offered
11.15.5 Zhejiang Medicine Related Developments
11.16 Biocon
11.16.1 Biocon Corporation Information
11.16.2 Biocon Description and Business Overview
11.16.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Biocon Products Offered
11.16.5 Biocon Related Developments
11.17 Johnson Matthey
11.17.1 Johnson Matthey Corporation Information
11.17.2 Johnson Matthey Description and Business Overview
11.17.3 Johnson Matthey Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Johnson Matthey Products Offered
11.17.5 Johnson Matthey Related Developments
11.18 Hisun Pharmacy
11.18.1 Hisun Pharmacy Corporation Information
11.18.2 Hisun Pharmacy Description and Business Overview
11.18.3 Hisun Pharmacy Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Hisun Pharmacy Products Offered
11.18.5 Hisun Pharmacy Related Developments
11.19 Cambrex
11.19.1 Cambrex Corporation Information
11.19.2 Cambrex Description and Business Overview
11.19.3 Cambrex Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Cambrex Products Offered
11.19.5 Cambrex Related Developments
11.20 Shandong Xinhua Pharmaceutical
11.20.1 Shandong Xinhua Pharmaceutical Corporation Information
11.20.2 Shandong Xinhua Pharmaceutical Description and Business Overview
11.20.3 Shandong Xinhua Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Shandong Xinhua Pharmaceutical Products Offered
11.20.5 Shandong Xinhua Pharmaceutical Related Developments
11.21 Lonza group
11.21.1 Lonza group Corporation Information
11.21.2 Lonza group Description and Business Overview
11.21.3 Lonza group Sales, Revenue and Gross Margin (2015-2020)
11.21.4 Lonza group Products Offered
11.21.5 Lonza group Related Developments
11.22 Huahai Pharmaceutical
11.22.1 Huahai Pharmaceutical Corporation Information
11.22.2 Huahai Pharmaceutical Description and Business Overview
11.22.3 Huahai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.22.4 Huahai Pharmaceutical Products Offered
11.22.5 Huahai Pharmaceutical Related Developments
11.23 Haerbin Pharmaceutical Group
11.23.1 Haerbin Pharmaceutical Group Corporation Information
11.23.2 Haerbin Pharmaceutical Group Description and Business Overview
11.23.3 Haerbin Pharmaceutical Group Sales, Revenue and Gross Margin (2015-2020)
11.23.4 Haerbin Pharmaceutical Group Products Offered
11.23.5 Haerbin Pharmaceutical Group Related Developments
11.24 Cipla
11.24.1 Cipla Corporation Information
11.24.2 Cipla Description and Business Overview
11.24.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
11.24.4 Cipla Products Offered
11.24.5 Cipla Related Developments
11.25 Tian Yao
11.25.1 Tian Yao Corporation Information
11.25.2 Tian Yao Description and Business Overview
11.25.3 Tian Yao Sales, Revenue and Gross Margin (2015-2020)
11.25.4 Tian Yao Products Offered
11.25.5 Tian Yao Related Developments
11.26 Lupin
11.26.1 Lupin Corporation Information
11.26.2 Lupin Description and Business Overview
11.26.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
11.26.4 Lupin Products Offered
11.26.5 Lupin Related Developments
11.27 North East Pharmaceutical
11.27.1 North East Pharmaceutical Corporation Information
11.27.2 North East Pharmaceutical Description and Business Overview
11.27.3 North East Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.27.4 North East Pharmaceutical Products Offered
11.27.5 North East Pharmaceutical Related Developments
11.28 Albemarle
11.28.1 Albemarle Corporation Information
11.28.2 Albemarle Description and Business Overview
11.28.3 Albemarle Sales, Revenue and Gross Margin (2015-2020)
11.28.4 Albemarle Products Offered
11.28.5 Albemarle Related Developments
11.29 Shandong Lukang Pharmaceutical
11.29.1 Shandong Lukang Pharmaceutical Corporation Information
11.29.2 Shandong Lukang Pharmaceutical Description and Business Overview
11.29.3 Shandong Lukang Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.29.4 Shandong Lukang Pharmaceutical Products Offered
11.29.5 Shandong Lukang Pharmaceutical Related Developments
11.30 Jiangsu Hengrui Medicine
11.30.1 Jiangsu Hengrui Medicine Corporation Information
11.30.2 Jiangsu Hengrui Medicine Description and Business Overview
11.30.3 Jiangsu Hengrui Medicine Sales, Revenue and Gross Margin (2015-2020)
11.30.4 Jiangsu Hengrui Medicine Products Offered
11.30.5 Jiangsu Hengrui Medicine Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Active Pharmaceutical Ingredient Market Estimates and Projections by Region
12.1.1 Global Active Pharmaceutical Ingredient Sales Forecast by Regions 2021-2026
12.1.2 Global Active Pharmaceutical Ingredient Revenue Forecast by Regions 2021-2026
12.2 North America Active Pharmaceutical Ingredient Market Size Forecast (2021-2026)
12.2.1 North America: Active Pharmaceutical Ingredient Sales Forecast (2021-2026)
12.2.2 North America: Active Pharmaceutical Ingredient Revenue Forecast (2021-2026)
12.2.3 North America: Active Pharmaceutical Ingredient Market Size Forecast by Country (2021-2026)
12.3 Europe Active Pharmaceutical Ingredient Market Size Forecast (2021-2026)
12.3.1 Europe: Active Pharmaceutical Ingredient Sales Forecast (2021-2026)
12.3.2 Europe: Active Pharmaceutical Ingredient Revenue Forecast (2021-2026)
12.3.3 Europe: Active Pharmaceutical Ingredient Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Active Pharmaceutical Ingredient Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Active Pharmaceutical Ingredient Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Active Pharmaceutical Ingredient Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Active Pharmaceutical Ingredient Market Size Forecast by Region (2021-2026)
12.5 Latin America Active Pharmaceutical Ingredient Market Size Forecast (2021-2026)
12.5.1 Latin America: Active Pharmaceutical Ingredient Sales Forecast (2021-2026)
12.5.2 Latin America: Active Pharmaceutical Ingredient Revenue Forecast (2021-2026)
12.5.3 Latin America: Active Pharmaceutical Ingredient Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Active Pharmaceutical Ingredient Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Active Pharmaceutical Ingredient Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Active Pharmaceutical Ingredient Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Active Pharmaceutical Ingredient Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Active Pharmaceutical Ingredient Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Active Pharmaceutical Ingredient Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Active Pharmaceutical Ingredient Market Segments
Table 2. Ranking of Global Top Active Pharmaceutical Ingredient Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Active Pharmaceutical Ingredient Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Synthetic API
Table 5. Major Manufacturers of Biotech API
Table 6. Major Manufacturers of Other
Table 7. Global Active Pharmaceutical Ingredient Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global Active Pharmaceutical Ingredient Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global Active Pharmaceutical Ingredient Sales by Regions 2015-2020 (K MT)
Table 10. Global Active Pharmaceutical Ingredient Sales Market Share by Regions (2015-2020)
Table 11. Global Active Pharmaceutical Ingredient Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Active Pharmaceutical Ingredient Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Active Pharmaceutical Ingredient Sales Share by Manufacturers (2015-2020)
Table 14. Global Active Pharmaceutical Ingredient Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Active Pharmaceutical Ingredient by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Active Pharmaceutical Ingredient as of 2019)
Table 16. Active Pharmaceutical Ingredient Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Active Pharmaceutical Ingredient Price (2015-2020) (USD/MT)
Table 19. Active Pharmaceutical Ingredient Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Active Pharmaceutical Ingredient Product Type
Table 21. Date of International Manufacturers Enter into Active Pharmaceutical Ingredient Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Active Pharmaceutical Ingredient Sales by Type (2015-2020) (K MT)
Table 24. Global Active Pharmaceutical Ingredient Sales Share by Type (2015-2020)
Table 25. Global Active Pharmaceutical Ingredient Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Active Pharmaceutical Ingredient Revenue Share by Type (2015-2020)
Table 27. Active Pharmaceutical Ingredient Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Active Pharmaceutical Ingredient Sales by Application (2015-2020) (K MT)
Table 29. Global Active Pharmaceutical Ingredient Sales Share by Application (2015-2020)
Table 30. North America Active Pharmaceutical Ingredient Sales by Country (2015-2020) (K MT)
Table 31. North America Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2020)
Table 32. North America Active Pharmaceutical Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2020)
Table 34. North America Active Pharmaceutical Ingredient Sales by Type (2015-2020) (K MT)
Table 35. North America Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 36. North America Active Pharmaceutical Ingredient Sales by Application (2015-2020) (K MT)
Table 37. North America Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 38. Europe Active Pharmaceutical Ingredient Sales by Country (2015-2020) (K MT)
Table 39. Europe Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2020)
Table 40. Europe Active Pharmaceutical Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2020)
Table 42. Europe Active Pharmaceutical Ingredient Sales by Type (2015-2020) (K MT)
Table 43. Europe Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 44. Europe Active Pharmaceutical Ingredient Sales by Application (2015-2020) (K MT)
Table 45. Europe Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Active Pharmaceutical Ingredient Sales by Region (2015-2020) (K MT)
Table 47. Asia Pacific Active Pharmaceutical Ingredient Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Active Pharmaceutical Ingredient Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Active Pharmaceutical Ingredient Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Active Pharmaceutical Ingredient Sales by Type (2015-2020) (K MT)
Table 51. Asia Pacific Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Active Pharmaceutical Ingredient Sales by Application (2015-2020) (K MT)
Table 53. Asia Pacific Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 54. Latin America Active Pharmaceutical Ingredient Sales by Country (2015-2020) (K MT)
Table 55. Latin America Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Active Pharmaceutical Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2020)
Table 58. Latin America Active Pharmaceutical Ingredient Sales by Type (2015-2020) (K MT)
Table 59. Latin America Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 60. Latin America Active Pharmaceutical Ingredient Sales by Application (2015-2020) (K MT)
Table 61. Latin America Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Active Pharmaceutical Ingredient Sales by Country (2015-2020) (K MT)
Table 63. Middle East and Africa Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Active Pharmaceutical Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Active Pharmaceutical Ingredient Sales by Type (2015-2020) (K MT)
Table 67. Middle East and Africa Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Active Pharmaceutical Ingredient Sales by Application (2015-2020) (K MT)
Table 69. Middle East and Africa Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 70. Teva Corporation Information
Table 71. Teva Description and Major Businesses
Table 72. Teva Active Pharmaceutical Ingredient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. Teva Product
Table 74. Teva Recent Development
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Major Businesses
Table 77. Novartis Active Pharmaceutical Ingredient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Novartis Product
Table 79. Novartis Recent Development
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Major Businesses
Table 82. Pfizer Active Pharmaceutical Ingredient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Pfizer Product
Table 84. Pfizer Recent Development
Table 85. Johnson & Johnson Corporation Information
Table 86. Johnson & Johnson Description and Major Businesses
Table 87. Johnson & Johnson Active Pharmaceutical Ingredient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Johnson & Johnson Product
Table 89. Johnson & Johnson Recent Development
Table 90. Mylan Corporation Information
Table 91. Mylan Description and Major Businesses
Table 92. Mylan Active Pharmaceutical Ingredient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Mylan Product
Table 94. Mylan Recent Development
Table 95. North China Pharmaceutical Group Corporation Information
Table 96. North China Pharmaceutical Group Description and Major Businesses
Table 97. North China Pharmaceutical Group Active Pharmaceutical Ingredient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. North China Pharmaceutical Group Product
Table 99. North China Pharmaceutical Group Recent Development
Table 100. Dr. Reddy’s Laboratories Corporation Information
Table 101. Dr. Reddy’s Laboratories Description and Major Businesses
Table 102. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Dr. Reddy’s Laboratories Product
Table 104. Dr. Reddy’s Laboratories Recent Development
Table 105. Roche Corporation Information
Table 106. Roche Description and Major Businesses
Table 107. Roche Active Pharmaceutical Ingredient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Roche Product
Table 109. Roche Recent Development
Table 110. Aurobindo pharma Corporation Information
Table 111. Aurobindo pharma Description and Major Businesses
Table 112. Aurobindo pharma Active Pharmaceutical Ingredient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Aurobindo pharma Product
Table 114. Aurobindo pharma Recent Development
Table 115. Sun Pharmaceutical Industries Corporation Information
Table 116. Sun Pharmaceutical Industries Description and Major Businesses
Table 117. Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Sun Pharmaceutical Industries Product
Table 119. Sun Pharmaceutical Industries Recent Development
Table 120. Boehringer Ingelheim GmbH Corporation Information
Table 121. Boehringer Ingelheim GmbH Description and Major Businesses
Table 122. Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Boehringer Ingelheim GmbH Product
Table 124. Boehringer Ingelheim GmbH Recent Development
Table 125. Bayer Corporation Information
Table 126. Bayer Description and Major Businesses
Table 127. Bayer Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Bayer Product
Table 129. Bayer Recent Development
Table 130. BASF Corporation Information
Table 131. BASF Description and Major Businesses
Table 132. BASF Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. BASF Product
Table 134. BASF Recent Development
Table 135. DSM Corporation Information
Table 136. DSM Description and Major Businesses
Table 137. DSM Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. DSM Product
Table 139. DSM Recent Development
Table 140. Zhejiang Medicine Corporation Information
Table 141. Zhejiang Medicine Description and Major Businesses
Table 142. Zhejiang Medicine Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Zhejiang Medicine Product
Table 144. Zhejiang Medicine Recent Development
Table 145. Biocon Corporation Information
Table 146. Biocon Description and Major Businesses
Table 147. Biocon Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. Biocon Product
Table 149. Biocon Recent Development
Table 150. Johnson Matthey Corporation Information
Table 151. Johnson Matthey Description and Major Businesses
Table 152. Johnson Matthey Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 153. Johnson Matthey Product
Table 154. Johnson Matthey Recent Development
Table 155. Hisun Pharmacy Corporation Information
Table 156. Hisun Pharmacy Description and Major Businesses
Table 157. Hisun Pharmacy Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 158. Hisun Pharmacy Product
Table 159. Hisun Pharmacy Recent Development
Table 160. Cambrex Corporation Information
Table 161. Cambrex Description and Major Businesses
Table 162. Cambrex Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 163. Cambrex Product
Table 164. Cambrex Recent Development
Table 165. Shandong Xinhua Pharmaceutical Corporation Information
Table 166. Shandong Xinhua Pharmaceutical Description and Major Businesses
Table 167. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 168. Shandong Xinhua Pharmaceutical Product
Table 169. Shandong Xinhua Pharmaceutical Recent Development
Table 170. Lonza group Corporation Information
Table 171. Lonza group Description and Major Businesses
Table 172. Lonza group Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 173. Lonza group Product
Table 174. Lonza group Recent Development
Table 175. Huahai Pharmaceutical Corporation Information
Table 176. Huahai Pharmaceutical Description and Major Businesses
Table 177. Huahai Pharmaceutical Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 178. Huahai Pharmaceutical Product
Table 179. Huahai Pharmaceutical Recent Development
Table 180. Haerbin Pharmaceutical Group Corporation Information
Table 181. Haerbin Pharmaceutical Group Description and Major Businesses
Table 182. Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 183. Haerbin Pharmaceutical Group Product
Table 184. Haerbin Pharmaceutical Group Recent Development
Table 185. Cipla Corporation Information
Table 186. Cipla Description and Major Businesses
Table 187. Cipla Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 188. Cipla Product
Table 189. Cipla Recent Development
Table 190. Tian Yao Corporation Information
Table 191. Tian Yao Description and Major Businesses
Table 192. Tian Yao Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 193. Tian Yao Product
Table 194. Tian Yao Recent Development
Table 195. Lupin Corporation Information
Table 196. Lupin Description and Major Businesses
Table 197. Lupin Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 198. Lupin Product
Table 199. Lupin Recent Development
Table 200. North East Pharmaceutical Corporation Information
Table 201. North East Pharmaceutical Description and Major Businesses
Table 202. North East Pharmaceutical Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 203. North East Pharmaceutical Product
Table 204. North East Pharmaceutical Recent Development
Table 205. Albemarle Corporation Information
Table 206. Albemarle Description and Major Businesses
Table 207. Albemarle Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 208. Albemarle Product
Table 209. Albemarle Recent Development
Table 210. Shandong Lukang Pharmaceutical Corporation Information
Table 211. Shandong Lukang Pharmaceutical Description and Major Businesses
Table 212. Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 213. Shandong Lukang Pharmaceutical Product
Table 214. Shandong Lukang Pharmaceutical Recent Development
Table 215. Jiangsu Hengrui Medicine Corporation Information
Table 216. Jiangsu Hengrui Medicine Description and Major Businesses
Table 217. Jiangsu Hengrui Medicine Active Pharmaceutical Ingredient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 218. Jiangsu Hengrui Medicine Product
Table 219. Jiangsu Hengrui Medicine Recent Development
Table 220. Global Active Pharmaceutical Ingredient Sales Forecast by Regions (2021-2026) (K MT)
Table 221. Global Active Pharmaceutical Ingredient Sales Market Share Forecast by Regions (2021-2026)
Table 222. Global Active Pharmaceutical Ingredient Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 223. Global Active Pharmaceutical Ingredient Revenue Market Share Forecast by Regions (2021-2026)
Table 224. North America: Active Pharmaceutical Ingredient Sales Forecast by Country (2021-2026) (K MT)
Table 225. North America: Active Pharmaceutical Ingredient Revenue Forecast by Country (2021-2026) (US$ Million)
Table 226. Europe: Active Pharmaceutical Ingredient Sales Forecast by Country (2021-2026) (K MT)
Table 227. Europe: Active Pharmaceutical Ingredient Revenue Forecast by Country (2021-2026) (US$ Million)
Table 228. Asia Pacific: Active Pharmaceutical Ingredient Sales Forecast by Region (2021-2026) (K MT)
Table 229. Asia Pacific: Active Pharmaceutical Ingredient Revenue Forecast by Region (2021-2026) (US$ Million)
Table 230. Latin America: Active Pharmaceutical Ingredient Sales Forecast by Country (2021-2026) (K MT)
Table 231. Latin America: Active Pharmaceutical Ingredient Revenue Forecast by Country (2021-2026) (US$ Million)
Table 232. Middle East and Africa: Active Pharmaceutical Ingredient Sales Forecast by Country (2021-2026) (K MT)
Table 233. Middle East and Africa: Active Pharmaceutical Ingredient Revenue Forecast by Country (2021-2026) (US$ Million)
Table 234. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 235. Key Challenges
Table 236. Market Risks
Table 237. Main Points Interviewed from Key Active Pharmaceutical Ingredient Players
Table 238. Active Pharmaceutical Ingredient Customers List
Table 239. Active Pharmaceutical Ingredient Distributors List
Table 240. Research Programs/Design for This Report
Table 241. Key Data Information from Secondary Sources
Table 242. Key Data Information from Primary Sources
List of Figures
Figure 1. Active Pharmaceutical Ingredient Product Picture
Figure 2. Global Active Pharmaceutical Ingredient Sales Market Share by Type in 2020 & 2026
Figure 3. Synthetic API Product Picture
Figure 4. Biotech API Product Picture
Figure 5. Other Product Picture
Figure 6. Global Active Pharmaceutical Ingredient Sales Market Share by Application in 2020 & 2026
Figure 7. Chemical
Figure 8. Deodorant
Figure 9. Dailylife
Figure 10. Active Pharmaceutical Ingredient Report Years Considered
Figure 11. Global Active Pharmaceutical Ingredient Market Size 2015-2026 (US$ Million)
Figure 12. Global Active Pharmaceutical Ingredient Sales 2015-2026 (K MT)
Figure 13. Global Active Pharmaceutical Ingredient Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Active Pharmaceutical Ingredient Sales Market Share by Region (2015-2020)
Figure 15. Global Active Pharmaceutical Ingredient Sales Market Share by Region in 2019
Figure 16. Global Active Pharmaceutical Ingredient Revenue Market Share by Region (2015-2020)
Figure 17. Global Active Pharmaceutical Ingredient Revenue Market Share by Region in 2019
Figure 18. Global Active Pharmaceutical Ingredient Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Active Pharmaceutical Ingredient Revenue in 2019
Figure 20. Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Figure 22. Global Active Pharmaceutical Ingredient Sales Market Share by Type in 2019
Figure 23. Global Active Pharmaceutical Ingredient Revenue Market Share by Type (2015-2020)
Figure 24. Global Active Pharmaceutical Ingredient Revenue Market Share by Type in 2019
Figure 25. Global Active Pharmaceutical Ingredient Market Share by Price Range (2015-2020)
Figure 26. Global Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Figure 27. Global Active Pharmaceutical Ingredient Sales Market Share by Application in 2019
Figure 28. Global Active Pharmaceutical Ingredient Revenue Market Share by Application (2015-2020)
Figure 29. Global Active Pharmaceutical Ingredient Revenue Market Share by Application in 2019
Figure 30. North America Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Active Pharmaceutical Ingredient Sales Market Share by Country in 2019
Figure 33. North America Active Pharmaceutical Ingredient Revenue Market Share by Country in 2019
Figure 34. U.S. Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Active Pharmaceutical Ingredient Market Share by Type in 2019
Figure 39. North America Active Pharmaceutical Ingredient Market Share by Application in 2019
Figure 40. Europe Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Active Pharmaceutical Ingredient Sales Market Share by Country in 2019
Figure 43. Europe Active Pharmaceutical Ingredient Revenue Market Share by Country in 2019
Figure 44. Germany Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Active Pharmaceutical Ingredient Market Share by Type in 2019
Figure 55. Europe Active Pharmaceutical Ingredient Market Share by Application in 2019
Figure 56. Asia Pacific Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Active Pharmaceutical Ingredient Sales Market Share by Region in 2019
Figure 59. Asia Pacific Active Pharmaceutical Ingredient Revenue Market Share by Region in 2019
Figure 60. China Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Active Pharmaceutical Ingredient Market Share by Type in 2019
Figure 83. Asia Pacific Active Pharmaceutical Ingredient Market Share by Application in 2019
Figure 84. Latin America Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Active Pharmaceutical Ingredient Sales Market Share by Country in 2019
Figure 87. Latin America Active Pharmaceutical Ingredient Revenue Market Share by Country in 2019
Figure 88. Mexico Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Active Pharmaceutical Ingredient Market Share by Type in 2019
Figure 95. Latin America Active Pharmaceutical Ingredient Market Share by Application in 2019
Figure 96. Middle East and Africa Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Active Pharmaceutical Ingredient Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Active Pharmaceutical Ingredient Revenue Market Share by Country in 2019
Figure 100. Turkey Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Active Pharmaceutical Ingredient Market Share by Type in 2019
Figure 107. Middle East and Africa Active Pharmaceutical Ingredient Market Share by Application in 2019
Figure 108. North America Active Pharmaceutical Ingredient Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 109. North America Active Pharmaceutical Ingredient Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Active Pharmaceutical Ingredient Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. Europe Active Pharmaceutical Ingredient Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Active Pharmaceutical Ingredient Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Asia Pacific Active Pharmaceutical Ingredient Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Active Pharmaceutical Ingredient Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Latin America Active Pharmaceut
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
